Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
74 /100
HIGH RISK
Score updated Oct 13, 2026

CVKD — Cadrenal Therapeutics, Inc. Dilution Risk Tracker

Track CVKD dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CVKD — Get alerts when the score changes →

As of October 13, 2026, Cadrenal Therapeutics, Inc. (CVKD) has a DilutionWatch DilutionScore of 74/100, rated HIGH dilution risk. Cadrenal Therapeutics, Inc. has a market capitalization of $3.11M, 3.57M shares outstanding, 17 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
72
💰 Cash Runway
95
📊 Float Risk
30
⚠️ Warrant Exposure
40
🔄 Convertible Debt
15

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 30%
💰 Capital Raise model 55%
• Critical: only 2.6 months cash remaining
📉 Score Deterioration model 10%
• Score in HIGH risk zone (74/100)
🔔 Track CVKD — Get forecast alerts →

Market Data

Market Cap$3.11M
Shares Outstanding3.57M
Float2.38M
Cash$2.39M
Debt$597.1K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore74/100DilutionWatch score record
Shares Outstanding3.57MVerified float table or market cache
Public Float2.38MVerified float table or market cache
Market Cap$3.11MMarket data cache
Cash Runway2.6 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 4 1, 8-K 2, EFFECT 1, SC 13G 1, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 13.9% shares (2026Q1 vs prior)
17 institutional holders · 138.4K shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 90.4K shares
#2 GEODE CAPITAL MANAGEMENT, LLC 21.6K shares
#3 VANGUARD FIDUCIARY TRUST CO 8.3K shares
+ 14 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest105.9K
Days to Cover1.1
% of Float4.5%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-03-31
xbrl XBRL CONVERTIBLE 2025-03-13
8-K 8K EVENT 2026-09-29
SC 13G BENEFICIAL OWNERSHIP 2026-08-07
EFFECT EFFECT 2026-07-20
Full SEC filing analysis available with free account →

Recent News

Factual CVKD Dilution Snapshot

Cadrenal Therapeutics, Inc. (CVKD) has a DilutionScore of 74/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

CVKD's DilutionScore is currently 74/100 (High risk), with 3 score changes tracked over 89 days. The score improved from 71/100 (High risk).

Period Score Risk Level Duration
Oct 01 – Oct 13, 202674/100HIGH13 days
Aug 22 – Sep 30, 202671/100HIGH40 days
Aug 14 – Aug 21, 202674/100HIGH7 days
Jul 16 – Aug 13, 202667/100HIGH29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

CVKD shares outstanding have increased 31.7% from 2.34M (Apr 2026) to 3.08M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 19, 20263.08M2.38M▲ 14.42%
Apr 27, 20262.51M2.08M▲ 4.89%
Apr 07, 20262.51M1.98M▲ 1.94%
Apr 03, 20262.34M1.95M▲ 20.76%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track CVKD Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment CVKD files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking CVKD — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for CVKD
CVKD FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.